An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

NCT01442064 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
608
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Genentech, Inc.